ChromaDex is now Niagen Bioscience

NASDAQ: NAGE

35+ clinical studies. Definitive science.

Our peer-reviewed, published scientific studies have expanded our NAD+ knowledge and validated our approach. Each clinical trial adds to the growing body of evidence supporting Niagen's efficacy. We pursue scientific excellence without compromise.

Browse clinical studies by health category

Niagen represents gold standard science, quality, and safety with over 35 clinical studies demonstrating safety and/or efficacy in human subjects. These peer-reviewed, published studies form the foundation of our scientific evidence.

Over 65% of registered nicotinamide riboside trials use Niagen.² We supply quality-tested, trusted Niagen NR material to 200+ leading research institutions through our CERP program, including Mayo Clinic, National Institute on Aging, Harvard, and Cambridge.

Independent validation comes from investigator-driven research. Over 90% of Niagen studies are third-party funded and investigator-initiated.

Select a health category to explore published clinical data.

Multiple selections allowed


{"statementLink":"","footerHtml":"","hideMobile":false,"hideTrigger":false,"disableBgProcess":false,"language":"en","position":"left","leadColor":"#146ff8","triggerColor":"#146ff8","triggerRadius":"50%","triggerPositionX":"right","triggerPositionY":"bottom","triggerIcon":"people","triggerSize":"medium","triggerOffsetX":20,"triggerOffsetY":20,"mobile":{"triggerSize":"small","triggerPositionX":"right","triggerPositionY":"bottom","triggerOffsetX":10,"triggerOffsetY":10,"triggerRadius":"50%"}}